Indeed, it has been recently described that olaparib toxicity in BRCA1-depleted cells is attenuated by treatments with a ROS scavenger, hypoxia, or OGG1 inhibitor46, suggesting that toxicity derived from PARPi in cancer cells might be attenuated by BER inhibition. This evidence concerns the gene BRCA1 and cancer.